The Rabbit Syndrome a Peculiar Extrapyramidal Reaction *

Ayd F. J. Jr. : Persistent dyskinesia: a neurologic complication of major tranquilizers. Intern. Drug Therapy Newsletter 1: (no. 6), 1966.

Barbeau A. : L-Dopa therapy in Parkinson's disease: A critical review of nine years' experience. Canad. Med. Ass. J. 101: 791–800, 1969.

Brandrup E. : Tetrabenacine treatment in persisting dyskinesia caused by psychopharmaca. Amer. J. Psychiat. 118: 551–552, 1961.

Christensen E. , Moller J. E. , and Faurbye A. : Neuropathological investigation of 28 brains from patients with dyskinesia. Acta Psychiat. Scand. 46: 14–23, 1970.

Cotzias G. C. , Papavasiliou P. S. , and Gellene R. : Modification of parkinsonism. Chronic treatment with L-DOPA. New Eng. J. Med. 280: 337–345, 1969.

Crane G. E. : Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. Amer. J. Psychiat. 124: 40–48 (Suppl.), 1968.

Ernst A. M. : Relation between the action of dopamine and apomorphine and their O-methylated derivatives upon the CNS. Psychopharmacologia 7: 391–399, 1965.

Eveloff H. H. : A case of amphetamine induced-dyskinesia. J.A.M.A. 204: 181, 1968.

Hadzovic S. , and Ernst A. M. : The effect of 5-hydroxytryptamine and 5-hydroxy-tryptophan on extrapyramidal function. European J. Pharmacol. 6: 90–95, 1969.

Jonas W. , and Scheel-Kruger : Amphetamine induced stereotyped behaviour correlated with the accumulation of O-methylated dopamine. Arch Int. Pharmacodyn. 177: 379–389, 1969.

Kline N. S. : On the rarity of irreversible oral dyskinesias following phenothiazines. Amer. J. Psychiat., 124: 48–54(Suppl.), 1968.

Mattson R. H. , and Calverley J. R. : Dextroamphetamine-sulfate-induced dyskinesias. J.AM.A. 204: 400–402, 1968.

Pakkenberg H. : The effect of tetrabenazine in some hyperkinetic syndromes. Acta Neurol. Scand., 44: 391–393, 1968.

Sourkes T. L. , and Poirier L. J. : Neurochemical bases of tremor and other disorders of movement. Canad. Med. Ass. J. 94: 53–60, 1966.

Villeneuve A. , Lavallee J. C. , et Lemieux L. H. : Dyskinesie tardive post-neuroleptique. Laval Med. 40: 832–837, 1969.

Villeneuve A. , Gagnon A. , et Deschambault M. : Effects du sevrage des neuroleptiques chez les malades psychiatriques. Laval Med. 41: 512–521, 1970.

Villeneuve A. , Gagnon A. , and Deschambault M. : Abrupt withdrawal of neuroleptics. Behav. Neuropsychiat. (in press).

Villeneuve A. , and Boszormenyi Z. : Druginduced dyskinesias and their treatment. Letter to the Editor, Lancet 1: 353–354, 1970.

Villeneuve A. , Boszormenyi Z. , Deschambault M. , et Lachance R. : Tentative de traitement de la dyskinesie post-neuro-leptique de type permanent. Laval Med. 41: 923–933, 1970.

Villeneuve A. , Chabot C. : Unpublished observation, 1967.

Villeneuve A. , Neuroleptics and Extra-pyramidal Symptoms. Dyskinesias of the permanent type, the rabbit syndrome and generalized tremor (Color Sound Movie, French), 1970.

Villeneuve A. , Boszormenyi Z. , Deschambault M. , and Lachance R. : Treatment of permanent-like neuroleptic-induced dyskinesias (in preparation).

Yahr M. D. , Duvoisin R. C. , Schear M. J. , Barrett R. E. , and Hochn M. H. : Treatment of parkinsonism with levodopa. Arch. Neurol. 21: 343–354, 1969.